论文部分内容阅读
目的:给予冠心病患者阿托伐汀联合曲美他嗪治疗,研究其临床效果。方法:选取我院在2014年9月至2016年9月期间所收治的100例冠心病患者,利用抽签法将所有患者均分为治疗组与对照组,每组50例。给予对照组患者单纯阿托伐汀治疗,给予治疗组患者阿托伐汀联合曲美他嗪治疗,对比2组患者经过不同治疗后的组间数据。结果:经过不同方法治疗后,治疗组患者的临床总有效率明显提高,TC(总胆固醇)、TG(三酰甘油)、LDL-C(低密度脂蛋白胆固醇)明显降低,HDL-C(高密度脂蛋白胆固醇)显著提高,每周心绞痛发作次数以及每次心绞痛持续时间显著减少,对比对照组患者存在统计学意义(P<0.05)。结论:在冠心病患者治疗过程中应用阿托伐汀联合曲美他嗪治疗的临床疗效较为显著,可显著改善患者的心绞痛发作次数以及血脂情况。
Objective: To treat patients with coronary heart disease with atorvastatin combined with trimetazidine, to study its clinical effect. Methods: A total of 100 patients with CHD who were treated in our hospital from September 2014 to September 2016 were enrolled in this study. All patients were divided into treatment group and control group by balloting method, 50 cases in each group. Patients in the control group were treated with atorvastatin alone. Patients in the treatment group were treated with atorvastatin combined with trimetazidine. The data from two groups after treatment were compared. Results: After treatment by different methods, the total effective rate of patients in the treatment group was significantly higher than that of the control group (TC, TG, TG and LDL-C) and HDL-C (P <0.05). The number of angina attacks per week and the duration of each angina significantly decreased compared with the control group (P <0.05). Conclusion: The clinical efficacy of atorvastatin plus trimetazidine in the treatment of patients with coronary heart disease is more significant, which can significantly improve the number of patients with angina pectoris and blood lipids.